<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Exelon preparations; Rivastigmine" /><meta name="IX" content="Exelon preparations; Rivastigmine" /><title>Exelon®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="68984.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="68984.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=68984.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="61145.htm">4.11 Drugs for dementia</a> &gt; <a href="68979.htm">RIVASTIGMINE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="119738.htm" title="Previous: MEMANTINE HYDROCHLORIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="2071.htm" title="Next: 5 Infections">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a300028.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rivastigmine, Rivastigmine Tartrate</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Autonomic Drugs* 12:00 &gt; Parasympathomimetic (Cholinergic) Agents 12:04</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/17993-v.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Rivastigmine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: R &gt; Interactions of Rivastigmine</p></div></li></ul><ul><li><h3>British National Formulary (3)</h3></li><li><a href="61145.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">4.11 Drugs for dementia</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system</p></div></li><li><a href="68979.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">RIVASTIGMINE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.11 Drugs for dementia</p></div></li><li><a href="218732.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rivastigmine</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.11 Drugs for dementia &gt; RIVASTIGMINE</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1472.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rivastigmine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; R</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-17993-v.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rivastigmine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antidementia Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/08240.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rivastigmine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; R &gt; RI</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E4E3E0R0D822.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Rivastigmine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; R</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c333.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rivastigmine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; R</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_68979">RIVASTIGMINE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i849.htm" title="Go to appendix 1">Rivastigmine</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">mild to moderate dementia in Alzheimer’s disease or in Parkinson’s
disease</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">gastric or duodenal ulcers (or susceptibility to ulcers); monitor body-weight; sick sinus syndrome, conduction
abnormalities; history of asthma or chronic obstructive pulmonary
disease; history of seizures; bladder outflow obstruction; <b>interactions:</b> Appendix 1 (parasympathomimetics)</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">use with caution</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">use with caution</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">nausea, vomiting, diarrhoea, dyspepsia, anorexia,
weight loss, increased salivation, abdominal pain, bradycardia, dizziness,
headache, drowsiness, malaise, agitation, anxiety, tremor, confusion,
insomnia, extrapyramidal symptoms (and worsening of Parkinson’s disease),
sweating; <i>less commonly</i> atrial fibrillation, AV block,
depression, syncope; <i>rarely</i> gastric and duodenal
ulceration, angina, seizures, rash; <i>very rarely</i> gastro-intestinal
haemorrhage, pancreatitis, tachycardia, hypertension, hallucinations; <i>also reported</i> dehydration, hepatitis, restlessness, aggression,
sick sinus syndrome</p><div class="cAV"><h3>Note</h3> <p class="cAX">Transdermal administration less likely to
cause gastro-intestinal disturbance</p></div><div class="cAV"><h3>Note</h3> <p class="cAX">Treatment should be interrupted if gastro-intestinal
side-effects occur and withheld until their resolution—retitrate dose
if necessary</p></div></div><div class="cAF"><h2>Dose</h2> <p class="cR"><span class="cU">By mouth</span>, initially 1.5 mg twice daily,
increased in steps of 1.5 mg twice daily at intervals of at least
2 weeks according to response and tolerance; usual range 3–6 mg twice
daily; max. 6 mg twice daily; if treatment interrupted for more than
several days, treatment should be retitrated from 1.5 mg twice daily</p><p class="cR"><span class="cU">By transdermal application</span>, initially apply 4.6 mg/24
hours patch to clean, dry, non-hairy, non-irritated skin on back,
upper arm, or chest, removing after 24 hours and siting a replacement
patch on a different area (avoid using the same area for 14 days);
if well tolerated increase to 9.5 mg/24 hours patch daily after at
least 4 weeks; if treatment interrupted for more than several days,
treatment should be retitrated from 4.6 mg/24 hours patch</p><div class="cAT"><h3>Note</h3> <p class="cAX">When switching from oral to transdermal therapy,
patients taking 3–6 mg by mouth daily should initially switch to 4.6 mg/24
hours patch (then titrate as above); patients taking 9–12 mg by mouth
daily should switch to 9.5 mg/24 hours patch. The first patch should
be applied on the day following the last oral dose</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="218732.htm#_218732" title="Rivastigmine">Rivastigmine</a></li><li class="jN" id="_68984" style="margin: 0 0 0 20px;"><h1 class="title">Exelon®<span> (<a href="appendix-112803-N.htm#m264">Novartis</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Capsules</span>, <span>rivastigmine</span> (as hydrogen tartrate) 1.5 mg (yellow), net price 28-cap pack =
£33.25, 56-cap pack = £66.51; 3 mg (orange), 28-cap pack = £33.25,
56-cap pack = £66.51; 4.5 mg (red), 28-cap pack = £33.25, 56-cap pack
= £66.51; 6 mg (red/orange), 28-cap pack = £33.25, 56-cap pack = £66.51. 
    Label:
    21, 25</div><div class="cAY"><span class="cAB">Oral solution</span>, <span>rivastigmine</span> (as hydrogen tartrate) 2 mg/mL, net price 120 mL (with oral syringe)
= £99.14. 
    Label:
    21</div><div class="cAY"><span class="cAB">Patches</span>, self-adhesive, beige, rivastigmine
4.6 mg/24 hours, net price 30 = £77.97; 9.5 mg/24 hours, 30 = £77.97<div class="cAQ"><div class="cAV"><h3>Note</h3> <p class="cAX">The <a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="29404.htm#_200790"><i>Scottish Medicines
Consortium</i></a> has advised (October 2007) that <span class="cZ">Exelon</span>® patches
should be restricted for use in patients with moderately severe Alzheimer’s
disease under the conditions of the NICE guidance (September 2007)
and when a transdermal patch is an appropriate choice of formulation</p></div></div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="119738.htm">Previous: MEMANTINE HYDROCHLORIDE</a> | <a class="top" href="68984.htm#">Top</a> | <a accesskey="]" href="2071.htm">Next: 5 Infections</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>